FDA Clamping Down on Abuse of an OTC Decongestant
THURSDAY, March 25, 2021 (HealthDay News) — Makers of inhalers that contain the nasal decongestant propylhexedrine should make design changes to prevent misuse, the U.S. Food and Drug Administration says. Propylhexedrine is a nasal decongestant in over-the-counter inhalers, and right now is “only marketed under the brand name Benzedrex,” theContinue Reading